Michelle McCluskey
Family · Talbott, TNNPI 1396756342
Payments from drug & device makers
Across 201 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$358
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$299
- Lilly USA, LLC$267
- Takeda Pharmaceuticals U.S.A., Inc.$227
- Esperion Therapeutics, Inc.$106
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,381100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 64 | $1,120 |
| AbbVie | 19 | $358 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $299 |
| Lilly USA, LLC | 22 | $267 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $227 |
| Esperion Therapeutics, Inc. | 7 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Amgen | 5 | $87 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| AstraZeneca | 6 | $85 |
| Pfizer | 5 | $82 |
| Abbott | 3 | $65 |
| Genentech USA, Inc. | 4 | $57 |
| Phathom Pharmaceuticals, Inc. | 5 | $57 |
| Philips North America LLC | 3 | $55 |
| Novartis | 3 | $52 |
| Johnson & Johnson | 3 | $52 |
| Bayer | 3 | $51 |
| Boehringer Ingelheim | 3 | $47 |
| Eisai Inc. | 2 | $35 |
| GSK | 1 | $22 |
| Gilead | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$3,381 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 68 | $81,493 |
| EliquisApixaban | 42 | $53,287 |
| MounjaroTirzepatide | 34 | $39,145 |
| TrulicityDulaglutide | 17 | $21,241 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $18,186 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $3,270 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 92 | $3,101 |
| Omeprazole | 124 | $2,033 |
| Levothyroxine Sodium | 290 | $2,025 |
| Bupropion XlBupropion Hcl | 64 | $1,923 |
| SynthroidLevothyroxine Sodium | 26 | $1,815 |
| Pantoprazole Sodium | 153 | $1,681 |
| Famotidine | 71 | $1,616 |
| Potassium Chloride | 68 | $1,488 |
| Atorvastatin Calcium | 216 | $1,421 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,120 | $81,49368 claims |
| Lilly USA, LLCMounjaro, Trulicity | $267 | $60,38751 claims |
| PfizerEliquis | $82 | $53,28742 claims |
| GSKTrelegy Ellipta | $22 | $18,18622 claims |
| AbbVieSynthroid | $358 | $1,81526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Talbott
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.